Table of Contents
Report Contents
- 1. Introduction
- 2. Stroke therapy survey
- 3. Survey participants
- 4. Stroke diagnosis
- 5. Limitations of stroke diagnostics
- 6. Drug Classes used to treat transient Ischaemic attack (TIA)
- 7. Drug classes used to treat Ischaemic Stroke
- 8. Antiplatelet drugs used to treat Ischaemic Stroke
- 9. Anticoagulant drugs used to treat Ischaemic Stroke
- 10. Thrombolytic drugs used to treat Ischaemic Stroke
- 11. Combined drugs used to treat Ischaemic Stroke
- 12. The use of drug therapy and/or surgery to treat Haemorrhagic Stroke
- 13. Drugs used to treat Haemorrhagic Stroke
- 14. The use of combined drugs to treat Haemorrhagic Stroke
- 15. Surgical methods to treat Haemorrhagic Stroke
- 16. Study participants
Appendix 1
Figures
- Figure 3.1 Participant Countries
- Figure 3.2 Participant Organisations
- Figure 3.3 Participating Physicians
- Figure 4.1 Percentage of patients diagnosed with Transient Ischaemic
Attack (TIA)
- Figure 4.2 Percentage of patients diagnosed with Ischaemic Stroke
- Figure 4.3 Percentage of patients diagnosed with Haemorrhagic Stroke
- Figure 4.4 Percentage patients with other conditions
- Figure 4.5 Average percentage of patients with Transient Ischaemic Attack
(TIA), Ischaemic Stroke, Haemorrhagic Stroke or other conditions
- Figure 4.6 Average percentage of patients tested for Stroke, and diagnosed
with other conditions
- Figure 5.1 Limitations in the diagnosis of Stroke, reported by study
participants
- Figure 6.1 Percentage of patients receiving antiplatelet drugs in
Transient Ischaemic Attack (TIA)
- Figure 6.2 Percentage of patients receiving anticoagulant drugs in
Transient Ischaemic Attack (TIA)
- Figure 6.3 Percentage of patients receiving thrombolytic drugs in
Transient Ischaemic Attack (TIA)
- Figure 6.4 Percentage of patients receiving other drugs in Transient
Ischaemic Attack (TIA)
- Figure 6.5 Average percentage of Transient Ischaemic Attack (TIA) patients
receiving antiplatelet, anticoagulant, thrombolytic or other drugs
- Figure 7.1 Percentage of patients receiving antiplatelet drugs in
Ischaemic Stroke
- Figure 7.2 Percentage of patients receiving anticoagulant drugs in
Ischaemic Stroke
- Figure 7.3 Percentage of patients receiving thrombolytics drugs in
Ischaemic Stroke
- Figure 7.4 Percentage of patients receiving other drugs in Ischaemic Stroke
- Figure 7.5 Average percentage of Ischaemic Stroke patients prescribed
antiplatelet, anticoagulant, thrombolytic or other drugs
- Figure 8.1 Percentage of patients receiving aspirin in Ischaemic Stroke
- Figure 8.2 Percentage of patients receiving dipyridamole in Ischaemic
Stroke
- Figure 8.3 Percentage of patients receiving clopidogrel in Ischaemic Stroke
- Figure 8.4 Percentage of patients receiving dipyridamol/aspirin in
Ischaemic Stroke
- Figure 8.5 Percentage of patients receiving ticlopidine in Ischaemic Stroke
- Figure 8.6 Percentage of patients receiving other drugs in Ischaemic Stroke
- Figure 8.7 Average percentage of patients prescribed specific antiplatelet
drugs for the treatment of Ischaemic Stroke
- Figure 8.8 Other antiplatelet drugs prescribed to patients with Ischaemic
Stroke
- Figure 9.1 Percentage of patients receiving the anticoagulant warfarin in
the treatment of Ischaemic Stroke
|
Related Report
|
View Cart
